Advertisement
UK markets close in 28 minutes
  • FTSE 100

    8,440.10
    +58.75 (+0.70%)
     
  • FTSE 250

    20,651.57
    +120.27 (+0.59%)
     
  • AIM

    790.50
    +6.80 (+0.87%)
     
  • GBP/EUR

    1.1621
    +0.0010 (+0.09%)
     
  • GBP/USD

    1.2509
    -0.0015 (-0.12%)
     
  • Bitcoin GBP

    48,837.55
    -339.27 (-0.69%)
     
  • CMC Crypto 200

    1,280.21
    -77.80 (-5.73%)
     
  • S&P 500

    5,218.50
    +4.42 (+0.08%)
     
  • DOW

    39,482.97
    +95.21 (+0.24%)
     
  • CRUDE OIL

    79.46
    +0.20 (+0.25%)
     
  • GOLD FUTURES

    2,369.20
    +28.90 (+1.23%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,780.53
    +93.93 (+0.50%)
     
  • CAC 40

    8,232.25
    +44.60 (+0.54%)
     

Will Johnson & Johnson Win Authorization for Its COVID-19 Booster?

A U.S. Food and Drug Administration (FDA) advisory committee has reviewed Johnson & Johnson's (NYSE: JNJ) data supporting boosters of its COVID-19 vaccine. The FDA gets the final say in the matter, though. In this Motley Fool Live video recorded on Oct. 6, Motley Fool contributors Keith Speights and Brian Orelli discuss J&J's prospects for authorization of boosters.